6571 - 6580 of 8654 Results
Title
Year
-
OPENTitle: Reply to: Hypoxia treatment of Parkinson’s disease may disrupt the circadian systemJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-023-03281-9Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-023-03281-9Citation Count: 0
- Oligomeric α‐synuclein and β‐amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases2015OPENTitle: Oligomeric α‐synuclein and β‐amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseasesJournal Name: European Journal of NeurosciencePublisher: WileyVol: 43Issue #: 1Start Page: 3End Page: 16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.13056Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.13056Citation Count: 68
- 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's disease2018RESTRICTEDTitle: 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1734End Page: 1739Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27451Citation Count: 12
- Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology2021OPENTitle: Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathologyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 3Start Page: 1001End Page: 1017Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awab374Best OA location URL: https://hdl.handle.net/11392/2485539Citation Count: 20
-
OPENTitle: Early and Accurate Diagnosis of Parkinson Disease May Be Rooted in Seed Amplification AssaysJournal Name: Clinical ChemistryPublisher: Oxford University Press (OUP)Vol: 69Issue #: 11Start Page: 1209End Page: 1211Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/clinchem/hvad111Best OA location URL: https://academic.oup.com/clinchem/advance-article-pdf/doi/10.1093/clinchem/hvad111/51472471/hvad111.pdfCitation Count: 1
- Long-term exposure to low-level particulate air pollution and Parkinson's disease diagnosis - A Finnish register-based study2023OPENTitle: Long-term exposure to low-level particulate air pollution and Parkinson's disease diagnosis - A Finnish register-based studyJournal Name: Environmental ResearchPublisher: Elsevier BVVol: 229Issue #:Start Page: 115944End Page: 115944Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.envres.2023.115944Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S0013935123007363-ga1_lrg.jpgCitation Count: 11
- Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation in Parkinson’s disease (randomized controlled trial)2022OPENTitle: Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation in Parkinson’s disease (randomized controlled trial)Journal Name: TrialsPublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13063-022-06160-9Best OA location URL: https://trialsjournal.biomedcentral.com/track/pdf/10.1186/s13063-022-06160-9Citation Count: 7
- LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts2023OPENTitle: LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohortsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00468-2Best OA location URL: https://escholarship.org/uc/item/7d2133k2Citation Count: 20
- Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohort2025OPENTitle: Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohortJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00919-yBest OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/148945Citation Count: 0
- Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils2019OPENTitle: Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrilsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 130Issue #:Start Page: 104525End Page: 104525Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104525Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104525Citation Count: 82